Innovent Presents the Results of the First Phase 3 Study of Mazdutide for Weight Management at the ADA’s 84th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 24, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company…
